IDiyas

For the Inventor, By the Inventor

San Francisco, CA, United States of America

Susan Barnett

USPTO Granted Patents = 29 

 

Average Co-Inventor Count = 3.1

ph-index = 7

Forward Citations = 224(Granted Patents)


Location History:

  • Emeryville, CA (US) (2012 - 2014)
  • San Francisco, CA (US) (2003 - 2021)

Company Filing History:

goldMedal21 out of 245 
 
Novartis Vaccines & Diagnostics, Gmbh
 patents
silverMedal3 out of 656 
 
Chiron Corporation
 patents
bronzeMedal3 out of 3,923 
 
Novartis Ag
 patents
4. 1 out of 531 
 
Glaxosmithkline Biologicals Sa
 patents
5. 1 out of 3 
 
Universaity of Stellenbosch
 patents
6. 1 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2003-2021

Loading Chart...
Loading Chart...
29 patents (USPTO):Explore Patents
1. 11058762 - Immunogenic compositions and uses thereof (2021-07-13),
2. 9598469 - HIV-1 south african subtype C env proteins (2017-03-21),
3. 9393300 - Immunogenic complexes of polyanionic carbomers and Env polypeptides and methods of manufacture and use thereof (2016-07-19),
4. 8647864 - Compositions and methods for generating an immune response utilizing alphavirus-based vector systems (2014-02-11),
5. 8637044 - Method of generating an immune response in a subject using fusion proteins comprising CD4 minimal modules and HIV Tat scaffold polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes (2014-01-28),
6. 8609109 - HIV vaccine formulations (2013-12-17),
7. 8568734 - Method for generating immune responses utilizing nucleic acids encoding fusion proteins comprising CD4 minimal modules and invasin polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes (2013-10-29),
8. 8541230 - Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof (2013-09-24),
9. 8470334 - Method of inducing an antiviral immune response against HIV-1 utilizing chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics (2013-06-25),
10. 8263394 - Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides, and uses thereof (2012-09-11),
11. 8226955 - Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopes (2012-07-24),
12. 8206720 - Fusion proteins comprising CD4 minimal modules and invasin polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutraliziation epitopes (2012-06-26),
13. 8197819 - Env polypeptide complexes and methods of use (2012-06-12),
14. 8173137 - Polycistronic HIV vector constructs (2012-05-08),
15. 8168418 - Expression of HIV polypeptides and production of virus-like particles (2012-05-01),

Title: Susan Barnett: Pioneering Innovations in Immunogenic Compositions

Introduction:

Susan Barnett, a visionary inventor based in San Francisco, CA, has made significant contributions to the field of immunology with her groundbreaking patents and innovative research. With an impressive portfolio of 29 patents to her name, Susan's work has revolutionized the way we approach immunogenic compositions.

Latest Patents:

Susan's latest patents include cutting-edge inventions such as "Immunogenic compositions and uses thereof," which focus on delivering antigenic epitopes in two different forms to induce immune responses effectively. Another notable patent is "HIV-1 South African Subtype C env proteins," which explores polynucleotides encoding immunogenic HIV polypeptides for various applications, including immunization and production of HIV polypeptides.

Career Highlights:

Throughout her illustrious career, Susan Barnett has worked with industry giants such as Novartis Vaccines & Diagnostics and Chiron Corporation. Her expertise and dedication have led to the development of groundbreaking technologies that have the potential to transform the field of immunology.

Collaborations:

Susan has collaborated closely with esteemed peers in the industry, including Jan Zur Megede and Indresh K Srivastava. Together, they have pioneered innovative approaches to immunogenic compositions and set new standards for research in the field.

Conclusion:

In conclusion, Susan Barnett's pioneering work in the realm of immunogenic compositions serves as a testament to her ingenuity and dedication to advancing scientific knowledge. Her patents and collaborations have significantly impacted the field of immunology, paving the way for future breakthroughs and innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…